EUCTR2005-003625-46-IT进行中（未招募）不适用
EFFICACY OF ORAL SODIUM CROMOGLICATE IN THE IRRITABLE BOWEL SYNDROME: A DOUBLE BLIND PLACEBO CONTROLLED MULTICENTRE RANDOMISED STUDY
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with IBS symptons (according to ROMA II)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patients with previously surgical treatment of abdomen; use of intestinal drug (motility)
研究者
相似试验
进行中（未招募）
不适用
EFFICACY OF ORAL SODIUM CROMOGLICATE IN PATIENTS WITH IRRITABLE BOWEL SYNDROME: A MULTI-CENTRE, RANDOMIZED, GROUP COMPARATIVE, DOUBLE -BLIND, PLACEBO CONTROLLED STUDYIRRITABLE BOWEL SYNDROMEEUCTR2005-003625-46-PLItalchimici S.p.A.180
进行中（未招募）
不适用
EFFICACY OF ORAL SODIUM CROMOGLICATE IN PATIENTS WITH IRRITABLE BOWELSYNDROME: A MULTI-CENTRE, RANDOMIZED, GROUP COMPARATIVE, DOUBLE -BLIND,PLACEBO CONTROLLED STUDYIRRITABLE BOWEL SYNDROMEMedDRA version: 12.0Level: LLTClassification code 10023003Term: Irritable bowel syndromeEUCTR2005-003625-46-SKItalchimici S.p.A.180
进行中（未招募）
1 期
EFFICACY OF ORAL SODIUM CROMOGLICATE IN PATIENTS WITH IRRITABLE BOWELSYNDROME: A MULTI-CENTRE, RANDOMIZED, GROUP COMPARATIVE, DOUBLE -BLIND,PLACEBO CONTROLLED STUDYIRRITABLE BOWEL SYNDROMEMedDRA version: 12.0Level: LLTClassification code 10023003Term: Irritable bowel syndromeEUCTR2005-003625-46-CZItalchimici S.p.A.180
已完成
不适用
Assessment of the effects of topical sodium cromoglicate on itch and flare in human skinISRCTN35671014Hewlett Healthcare Ltd (UK)60
招募中
不适用
Sodium Chloride supplementation in reducing incidence of low sodium levels in children with epilepsy receiving Oxcarbazepine.CTRI/2021/12/038388All India Institute of Medical Sciences